Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Goodwill & Intangibles (2023 - 2025)

Tonix Pharmaceuticals Holding has reported Goodwill & Intangibles over the past 3 years, most recently at $120000.0 for Q4 2025.

  • Quarterly results put Goodwill & Intangibles at $120000.0 for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $120000.0 (changed 0.0% YoY), and the annual figure for FY2025 was $120000.0, changed 0.0%.
  • Goodwill & Intangibles for Q4 2025 was $120000.0 at Tonix Pharmaceuticals Holding, roughly flat from $120000.0 in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for TNXP hit a ceiling of $11.2 million in Q2 2023 and a floor of $120000.0 in Q2 2024.
  • Median Goodwill & Intangibles over the past 3 years was $120000.0 (2024), compared with a mean of $2.3 million.
  • Biggest five-year swings in Goodwill & Intangibles: tumbled 98.93% in 2024 and later changed 0.0% in 2025.
  • Tonix Pharmaceuticals Holding's Goodwill & Intangibles stood at $1.1 million in 2023, then plummeted by 88.94% to $120000.0 in 2024, then changed by 0.0% to $120000.0 in 2025.
  • The last three reported values for Goodwill & Intangibles were $120000.0 (Q4 2025), $120000.0 (Q3 2025), and $120000.0 (Q2 2025) per Business Quant data.